Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950138-21-000224
Filing Date
2021-03-16
Accepted
2021-03-16 16:26:29
Documents
1
Period of Report
2021-03-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3487
  Complete submission text file 0000950138-21-000224.txt   4904
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1225
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E, SUITE 310 SEATTLE WA 98102
Business Address
Paya Carlos V (Reporting) CIK: 0001606244 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 21746084